HKI6MAG-99K

MILLIPLEX^® Human Kidney Injury Magnetic Bead Panel 6 - Toxicity Multiplex Assay

The analytes available for this multiplex kit are: β-2-Microglobulin (β2M), Clusterin, Cystatin C, RBP4.

• UNSPSC 코드: 12161503
• eCl@ss: 32161000
• NACRES: NA.84

속성

• Quality Level: 200
• 종 반응성: human
• 제조업체/상표: Milliplex^®
• assay range: accuracy: 103-133%; intra-assay cv: <10; sensitivity: 0.10-3.42 ng/mL; (MinDC+2SD); standard curve range: 0.05-50 ng/mL; (β-2-Microglobulin (β2M)); standard curve range: 0.10-100 ng/mL; (RBP4); standard curve range: 0.59-600 ng/mL; (Cystatin C); standard curve range: 2.93-3,000 ng/mL; (Clusterin)
• 기술: multiplexing: suitable
• 검출 방법: fluorometric (Luminex xMAP)
• 배송 상태: wet ice

설명

일반 설명

Maintenance of physiological balance in the body is attributed in part to normal kidney function. Altered kidney function due to injury, drug toxicity or kidney failure may be life threatening. Toxicity is the leading cause of drug failure, so research is expanding in search of more sensitive, rapid methods to determine organ-specific damage as quickly as possible. Traditionally, blood urea nitrogen (BUN) and serum creatinine tests have been used to determine drug-induced damage to the kidney. These tests only detect kidney damage after it begins and do not allow for the elucidation of where in the kidney the damage has occurred. Specificity and earlier detection of kidney injury is vital, and this area of research is expanding in search of more sensitive, rapid methods for determining the specific area of damage in kidney.

The MILLIPLEX^® portfolio provides valuable research assays to investigate multiple biomarkers of kidney injury in human serum and plasma samples using the [Luminex^® xMAP^® instrument platform.

The MILLIPLEX^® Human Kidney Injury Bead Panel 6 contains all the components necessary to measure the following four biomarkers in any combination using [Luminex^® xMAP^® technology: β-2-Microglobulin (β2M), Clusterin, Cystatin C, RBP4. The kit uses a 96-well format, contains a lyophilized standard cocktail, two quality controls and can measure up to 38 serum or plasma samples in duplicate.

Panel Type: Toxicity

특이성

Cross Reactivty
There was no or negligible cross-reactivity between the antibodies for an analyte and any of the other analytes within a panel.

애플리케이션

• Analytes: β-2-Microglobulin (β2M), Clusterin, Cystatin C, RBP4
• Recommended Sample type: serum and plasma
• Recommended Sample dilution: 1:3,000 in kit Assay Buffer. Customers should determine the optimal dilution factor for their samples. Our recommendations are based on serum and plasma samples from normal subjects.
• Assay Run Time: Overnight
• Research Category: Toxicity

특징 및 장점

Design your multiplex kit by choosing available analytes within this panel.

포장

Everything you need in a single kit.

저장 및 안정성

Recommended storage for kit components is 2 - 8°C.

기타 정보

Please contact Technical Service for linearity of dilution.

Sensitivity: Please see kit protocol for individual assay sensitivities.

법적 정보

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

면책조항

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

안전성 정보

• 픽토그램: GHS06,GHS08,GHS05,GHS09
• 신호어: Danger
• 유해 및 위험 성명서: H302 + H332,H311,H317,H318,H373,H411
• 예방조치 성명서: P273 - P280 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 - P314
• Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
• 표적 기관: Respiratory Tract
• Storage Class Code: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects